Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

Barclays logo

   Trade now with Barclays Stockbrokers   Trade now with Barclays   Sponsored by Barclays Stockbrokers

68.00p
   
  • Change Today:
      1.60p
  • 52 Week High: 102.00
  • 52 Week Low: 60.00
  • Currency: UK Pounds
  • Shares Issued: 518.23m
  • Volume: 227,355
  • Market Cap: £352.40m
  • RiskGrade: 172

Alliance Pharma Overview

Alliance Pharma is in the pharma and biotech sector and is currently trading at 68.00p per share. In the last year Alliance Pharma's share price has ranged from 60.00p to 102.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (19-02-2019)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 2.0% 2.2%
Div Cover 4.0 3.1
Op Mrgn 29.2% 21.1%
ROCE 85.8%  
Latest F'cast
P/E 12.7 14.9
PEG 0.3 n/a
Pr/Revenue 3.4 2.8
Pr/Book 1.7  
Latest F'cast
Revenue 6.0% 20.3%
PBT 27.7% -7.6%
EPS 38.7% -14.5%
DPS 10.0% 11.7%

Alliance Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 45.28 12.01 3.82p 10.6 1.8 +6% 0.91p 2.2%
31-Dec-14 43.54 10.16 3.36p 10.9 n/a -12% 1.00p 2.7%
31-Dec-15 48.34 15.18 3.52p 12.2 2.4 +5% 1.10p 2.6%
31-Dec-16 97.49 22.22 3.85p 12.3 1.4 +9% 1.21p 2.6%
31-Dec-17 103.31 28.37 5.34p 12.6 0.3 +39% 1.33p 2.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 124.23 26.20 4.57p 14.9 n/a -14% 1.49p 2.2%
31-Dec-19 144.47 32.33 5.03p 13.5 1.3 +10% 1.60p 2.4%
31-Dec-20 153.70 35.90 5.57p 12.2 1.2 +11% 1.79p 2.7%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Total Voting Rights 04-Feb-2019 15:40 RNS
Director Shareholding 23-Jan-2019 10:06 RNS
Pre-Close Trading Update 21-Jan-2019 07:00 RNS

Alliance Pharma ShareCast News

Alliance Pharma's revenues climb as 'star' produ... 21-Jan-2019 ShareCast
Alliance Pharma launches Xonvea in the UK 02-Oct-2018 ShareCast
Alliance Pharma overseas transformation continues 19-Sep-2018 ShareCast

Alliance Pharma Top Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 68.00p
Change Today 1.60p
% Change 2.41 %
52 Week High 102.00
52 Week Low 60.00
Volume 227,355
Shares Issued 518.23m
Market Cap £352.40m
RiskGrade 172

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
56.38% below the market average56.38% below the market average56.38% below the market average56.38% below the market average56.38% below the market average
75.86% above the sector average75.86% above the sector average75.86% above the sector average75.86% above the sector average75.86% above the sector average
Price Trend
22.61% above the market average22.61% above the market average22.61% above the market average22.61% above the market average22.61% above the market average
30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average
Income
35.96% below the market average35.96% below the market average35.96% below the market average35.96% below the market average35.96% below the market average
69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average69.23% above the sector average
Growth
81.12% above the market average81.12% above the market average81.12% above the market average81.12% above the market average81.12% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 20-Dec-18 14-Jun-18
Paid 10-Jan-19 11-Jul-18
Amount 0.49p 0.89p

Trades for 19-Feb-2019

Time Volume / Share Price
16:51 5,559 @ 66.80p
16:35 12,039 @ 68.00p
16:29 144 @ 67.80p
16:29 1,420 @ 68.20p
16:29 55 @ 68.00p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page